Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.73
-0.08 (-1.17%)
At close: Mar 20, 2026, 4:00 PM EDT
6.93
+0.20 (2.98%)
After-hours: Mar 20, 2026, 7:27 PM EDT
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $144.64 million as of March 20, 2026. Its market cap has increased by 153.13% in one year.
Market Cap
144.64M
Enterprise Value
102.21M
1-Year Change
153.13%
Ranking
Category
Stock Price
$6.73
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $144.64M, an increase of 117.53%. That is a compound annual growth rate of 18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 144.64M | 16.64% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | 66.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 154.13M |
| Heron Therapeutics | 154.09M |
| Codexis | 151.75M |
| Immunic | 151.34M |
| Agenus | 146.30M |
| Oramed Pharmaceuticals | 143.69M |
| Karyopharm Therapeutics | 141.80M |
| vTv Therapeutics | 141.67M |